CCChristine Cronin

Christine Cronin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christine Cronin has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Staff Perspectives on Normalizing and Sustaining Electronic Patient-Reported Outcomes Monitoring at Six US Health Systems

    by Roshan Paudel, Hajime Uno, Christine Cronin, Don S. Dizon, Hannah Hazard-Jenkins, Jessica Bian, Raymond U. Osarogiagbon, Sandra L. Wong, Deborah Schrag, Michael J. Hassett

    PURPOSE: We assessed the perspectives of staff from six health systems to understand how electronic Symptom Management (eSyM), an eSyM program that supports patients during chemotherapy and after surgery, is normalized and sustained. METHODS: Starting in 2019, we integrated eSyM into routine clinical practice and assessed its effectiveness using a cluster randomized stepped-wedge trial design. At least 1 year after implementation, we administered cross-sectional surveys to elicit the perspectives of physicians, nurses, advanced practice providers (APPs), hospital administrators, information technology, and research staff using the Normalization MeAsure Development (NoMAD) and the Clinical Sustainability Assessment Tool (CSAT). RESULTS: Of the 211 staff who initiated the survey, 169 (80%) completed it. Respondents included 64 nurses (38%), 38 physicians (23%), 20 research staff (12%), 17 APPs (10%), 16 administrators (10%), and nine information technologists (5%). The mean NoMAD familiarity score was 5.90 (standard deviation [SD], 3.06) and the mean score for eSyM becoming a part of routine practice was 4.84 (SD, 3.21), scored on a 0-10 scale. Compared with physicians, nurses reported higher familiarity scores and lower NoMAD domain scores for coherence , cognitive participation , and reflexive monitoring . CSAT scores (scored 1-7) demonstrated moderate sustainability (mean 4.52, SD, 1.61), ranging from a mean of 3.28 (SD, 1.48) among APPs to 5.75 (SD, 0.69) among IT staff. Of the CSAT items, engaged staff and leadership and organizational readiness had the highest (mean 4.89, SD, 1.73) and lowest (mean 4.18, SD, 1.73) scores, respectively ( P < .05). CONCLUSION: Clinical staff reported moderate levels of normalization and capacity for sustainability. Nurses and APPs reported lower levels of sustainability compared with physicians and administrators. Future studies should explore novel workflows and tools that support clinical staff who provide symptom management support.

  • Open Access

    Self‐reported overall well‐being and physical function among chemotherapy and surgery patients across six institutions

    by Michael J. Hassett, Christine M. Cronin, Angela C. Tramontano, Sandra L. Wong, Hajime Uno, Roshan Paudel, Jessica J. Bian, Don S. Dizon, Hannah Hazard‐Jenkins, Raymond U. Osarogiagbon, et al.

    Background: Electronic patient‐reported outcomes (ePROs) mitigate symptom burden among cancer patients. This study hypothesized that two single‐item quality of life measures, overall well‐being (OWB) and physical function (PFN), could provide distinct information that augment ePROs. Methods: eSyM, an electronic symptom management program, was deployed across six institutions for patients receiving chemotherapy or surgery for a suspected or confirmed thoracic, gastrointestinal, or gynecologic malignancy. eSyM prompts patients one to three times weekly to complete a 12‐item symptom questionnaire and two pictogram questions assessing OWB and PFN. The study identified characteristics associated with OWB/PFN; described correlations between OWB/PFN, severe symptoms, and total symptom burden; and characterized relationships between OWB/PFN and clinical outcomes. Results: From September 2019 to February 2024, 10,176 patients (3669 chemotherapy and 6507 surgery) submitted 78,433 questionnaires. The plurality reported mild impairment for OWB (chemotherapy, 41%; surgery, 45%) and PFN (chemotherapy, 43%; surgery, 39%). OWB and PFN were moderately correlated with each other (chemotherapy, 0.62; surgery, 0.58); with total symptom burden (chemotherapy: OWB 0.57, PFN 0.52; surgery: OWB 0.63, PFN 0.53); and with pain, fatigue, and decreased appetite (0.39–0.61). OWB and PFN varied by employment status and institution, and were associated with emergency department visits, admissions, and survival. Conclusions: Self‐reported OWB and PFN were moderately correlated with common symptoms, offered discriminant and face validity, and were associated with clinical outcomes. These measures supplemented information from a multi‐item questionnaire and may guide management for cancer patients by contextualizing symptom reports and functioning as a brief screen to identify patients at risk for moderate–severe symptoms or other serious outcomes.


  • Does Electronic Symptom Monitoring Improve Symptom Burden and Self-Efficacy Among Chemotherapy and Surgery Patients Across Six Cancer Centers?

    by Jessica J. Bian, Samira L. Dias, Paige A. Wright, Angela C. Tramontano, Christine M. Cronin, Raymond U. Osarogiagbon, Deb Schrag, Sandra L. Wong, Don S. Dizon, Hannah Hazard-Jenkins, et al.

    PURPOSE: The multicenter Symptom Management Implementation of Patient Reported Outcomes in Oncology Consortium developed electronic Symptom Management (eSyM), an electronic health record-based symptom management program, to reduce acute care utilization. We hypothesized that implementing eSyM would also improve self-reported symptom burden and self-efficacy. METHODS: eSyM was deployed via a pragmatic stepped-wedge cluster randomized trial for adults who started chemotherapy or had surgery for confirmed or suspected GI, gynecologic, or thoracic malignancies across six cancer centers from 2019 to 2023. In parallel, we administered a survey to two distinct cohorts: patients treated before and after eSyM deployment (ie, pre-live and post-live). A REDCap-based survey collected demographic and clinical characteristics and assessed six Patient-Reported Outcomes Measurement Information System measures: self-efficacy for symptom management, pain interference, anxiety, fatigue, depression, and physical function. Differences in mean T-scores were derived for the post-live versus pre-live cohorts among chemotherapy and surgery recipients. Multivariable regression models controlled for relevant patient and clinical characteristics. RESULTS: The pre-live cohort included 1,043 respondents (490 chemotherapy and 553 surgery); the post-live cohort included 1,046 respondents (535 chemotherapy and 511 surgery). After controlling for other clinical and demographic factors, the post-live chemotherapy cohort reported statistically significantly lower fatigue and anxiety, but the reductions did not meet the clinically meaningful threshold (adjusted mean T-score difference: –1.3 and –1.8, respectively; P < .05). The post-live surgery cohort reported statistically significantly lower fatigue and anxiety; the differences met the clinically meaningful threshold (–2.0 and –2.2, respectively; P < .01). CONCLUSION: eSyM deployment was associated with reduced symptom burden, but clinically meaningful differences were only observed in fatigue and anxiety scores among surgical patients. Future studies should investigate the mechanisms by which symptom reporting affects patient outcomes, such as improving patient-clinician communication, enhancing clinician attention to symptom management, or increasing patient self-efficacy.

  • Open Access

    Use of Patient-Reported Outcomes in Risk Prediction Model Development to Support Cancer Care Delivery: A Scoping Review

    by Roshan Paudel, Samira Dias, Carrie G. Wade, Christine Cronin, Michael J. Hassett

    PURPOSE: The integration of patient-reported outcomes (PROs) into electronic health records (EHRs) has enabled systematic collection of symptom data to manage post-treatment symptoms. The use and integration of PRO data into routine care are associated with overall treatment success, adherence, and satisfaction. Clinical trials have demonstrated the prognostic value of PROs including physical function and global health status in predicting survival. It is unknown to what extent routinely collected PRO data are used in the development of risk prediction models (RPMs) in oncology care. The objective of the scoping review is to assess how PROs are used to train risk RPMs to predict patient outcomes in oncology care. METHODS: Using the scoping review methodology outlined in the Joanna Briggs Institute Manual for Evidence Synthesis, we searched four databases (MEDLINE, CINAHL, Embase, and Web of Science) to locate peer-reviewed oncology articles that used PROs as predictors to train models. Study characteristics including settings, clinical outcomes, and model training, testing, validation, and performance data were extracted for analyses. RESULTS: Of the 1,254 studies identified, 18 met inclusion criteria. Most studies performed retrospective analyses of prospectively collected PRO data to build prediction models. Post-treatment survival was the most common outcome predicted. Discriminative performance of models trained using PROs was better than models trained without PROs. Most studies did not report model calibration. CONCLUSION: Systematic collection of PROs in routine practice provides an opportunity to use patient-reported data to develop RPMs. Model performance improves when PROs are used in combination with other comprehensive data sources.


  • Electronic Patient-Reported Outcomes in Oncology: Lessons from Six Cancer Centers

    by Christine Cronin, Fiona Barrett, Samira Dias, Sandra Wong, Loretta Pearson, Hannah Hazard-Jenkins, Jessica Bian, Don Dizon, Raymond Osarogiagbon, Deborah Schrag, et al.


  • Assessing Patient Readiness for an Electronic Patient-Reported Outcome–Based Symptom Management Intervention in a Multisite Study

    by Roshan Paudel, Angela C. Tramontano, Christine Cronin, Sandra L. Wong, Don S. Dizon, Hannah H. Jenkins, Jessica Bian, Raymond U. Osarogiagbon, Deborah Schrag, Michael J. Hassett

    PURPOSE: While the use of electronic patient-reported outcomes (ePROs) in routine clinical practice is increasing, barriers to patient engagement limit adoption. Studies have focused on technology access as a key barrier, yet other characteristics may also confound readiness to use ePROs including patients' confidence in using technology and confidence in asking clinicians questions. METHODS: To assess readiness to use ePROs, adult patients from six US-based health systems who started a new oncology treatment or underwent a cancer-directed surgery were invited to complete a survey that assessed access to and confidence in the use of technology, ease of asking clinicians questions about health, and symptom management self-efficacy. Multivariable ordinal logistic regression models were fit to assess the association between technology confidence, ease of asking questions, and symptom management self-efficacy. RESULTS: We contacted 3,212 individuals, and 1,043 (33%) responded. The median age was 63 years, 68% were female, and 75% reported having access to patient portals. Over 80% had two or more electronic devices. Most patients reported high technology confidence, higher ease of asking clinicians questions, and high symptom management self-efficacy (n = 692; 66%). Patients with high technology confidence also reported higher ease of asking nurses about their health (adjusted odds ratio [AOR], 4.58 [95% CI, 2.36 to 8.87]; P ≤ .001). Those who reported higher ease of asking nurses questions were more likely to report higher confidence in managing symptoms (AOR, 30.54 [95% CI, 12.91 to 72.30]; P ≤ .001). CONCLUSION: Patient readiness to use ePROs likely depends on multiple factors, including technology and communication confidence, and symptom management self-efficacy. Future studies should assess interventions to address these factors.


  • Cancer Caregivers’ Prognostic and End-of-Life Communication Needs and Experiences and their Impact

    by Anny T.H.R. Fenton, Kalen M. Fletcher, Deniz Kizildag, Nancy A. Borstelmann, Daniela Kessler, Christine Cronin, Anna C. Revette, Alexi A. Wright, Elizabeth Frank, Andrea C. Enzinger


  • Open Access

    eSyM: An Electronic Health Record–Integrated Patient-Reported Outcomes–Based Cancer Symptom Management Program Used by Six Diverse Health Systems

    by Michael J. Hassett, Christine Cronin, Terrence C. Tsou, Jason Wedge, Jessica Bian, Don S. Dizon, Hannah Hazard-Jenkins, Raymond U. Osarogiagbon, Sandra Wong, Ethan Basch, et al.

    PURPOSE: Collecting patient-reported outcomes (PROs) can improve symptom control and quality of life, enhance doctor-patient communication, and reduce acute care needs for patients with cancer. Digital solutions facilitate PRO collection, but without robust electronic health record (EHR) integration, effective deployment can be hampered by low patient and clinician engagement and high development and deployment costs. The important components of digital PRO platforms have been defined, but procedures for implementing integrated solutions are not readily available. METHODS: As part of the NCI's IMPACT consortium, six health care systems partnered with Epic to develop an EHR-integrated, PRO-based electronic symptom management program (eSyM) to optimize postoperative recovery and well-being during chemotherapy. The agile development process incorporated user-centered design principles that required engagement from patients, clinicians, and health care systems. Whenever possible, the system used validated content from the public domain and took advantage of existing EHR capabilities to automate processes. RESULTS: eSyM includes symptom surveys on the basis of the PRO-Common Terminology Criteria for Adverse Events (PRO-CTCAE) plus two global wellness questions; reminders and symptom self-management tip sheets for patients; alerts and symptom reports for clinicians; and population management dashboards. EHR dependencies include a secure Health Insurance Portability and Accountability Act-compliant patient portal; diagnosis, procedure and chemotherapy treatment plan data; registries that identify and track target populations; and the ability to create reminders, alerts, reports, dashboards, and charting shortcuts. CONCLUSION: eSyM incorporates validated content and leverages existing EHR capabilities. Build challenges include the innate technical limitations of the EHR, the constrained availability of site technical resources, and sites' heterogenous EHR configurations and policies. Integration of PRO-based symptom management programs into the EHR could help overcome adoption barriers, consolidate clinical workflows, and foster scalability and sustainability. We intend to make eSyM available to all Epic users.